Therapeutic strategy for pandrug-resistant Klebsiella pneumoniae severe infections: short-course treatment with colistin increases the in vivo and in vitro activity of double carbapenem regimen

Therapeutic strategy for pandrug-resistant Klebsiella pneumoniae severe infections: short-course treatment with colistin increases the in vivo and in vitro activity of double carbapenem regimen

Infections due to carbapenemase-producing Klebsiella pneumoniae represent an emerging threat due to the high mortality rate and lack of valid antimicrobial combinations, especially when the strain is colistin-resistant. We report a case of bloodstream infection due to pandrug-resistant K. pneumonia...

Full description

Bibliographic Details
Main Authors: Alessandra Oliva, Maria T. Mascellino, Alessia Cipolla, Alessandra D’Abramo, Annalisa De Rosa, Stefano Savinelli, Maria Rosa Ciardi, Claudio M. Mastroianni, Vincenzo Vullo
Format: Article
Language:English
Published: Elsevier 2015-04-01
Series:International Journal of Infectious Diseases
Subjects:
Double carbapenem
Colistin
Pan-drug resistant K. pneumoniae
Bloodstream infection
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971215000168

Internet

http://www.sciencedirect.com/science/article/pii/S1201971215000168

Similar Items